HomeInsightsStock Comparison

Gian Lifecare Ltd vs Thyrocare Technologies Ltd Stock Comparison

Gian Lifecare Ltd vs Thyrocare Technologies Ltd Stock Comparison

Last Updated on: Jul 26, 2025

Key Highlights

  • The Latest Trading Price of Gian Lifecare Ltd is ₹ 16.55 as of 25 Jul 15:30.
  • The P/E Ratio of Gian Lifecare Ltd changed from 9.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 29.6 on March 2020 to 39.4 on March 2025 . This represents a CAGR of 4.88% over 6 years.
  • The Market Cap of Gian Lifecare Ltd changed from ₹ 42.97 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 2618 crore on March 2020 to ₹ 3604 crore on March 2025 . This represents a CAGR of 5.47% over 6 years.
  • The revenue of Gian Lifecare Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Thyrocare Technologies Ltd for the Jun '25 is ₹ 197.93 crore as compare to the Mar '25 revenue of ₹ 191.75 crore. This represent the growth of 3.22%.
  • The ebitda of Gian Lifecare Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Thyrocare Technologies Ltd for the Jun '25 is ₹ 62.67 crore as compare to the Mar '25 ebitda of ₹ 61.66 crore. This represent the growth of 1.64%.
  • The net profit of Gian Lifecare Ltd changed from ₹ 0.26 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Thyrocare Technologies Ltd changed from ₹ 17.25 crore to ₹ 38.29 crore over 9 quarters. This represents a CAGR of 42.53% .
  • The Dividend Payout of Gian Lifecare Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 33.31 % on March 2020 to 116.18 % on March 2025 . This represents a CAGR of 23.15% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gian Lifecare Ltd

  • Gian Life Care Limited was incorporated as a Public Limited Company and registered with the Registrar of Companies, Uttar Pradesh, Kanpur with the name & style 'Gian Life Care Limited' pursuant to a Certificate of Incorporation dated November 06, 2018.
  • Subsequently, Company acquired the entire business of M/s Gian Pathology & X-Ray, sole proprietorship concern of its Promoter Mr. Arun Kumar Gupta w.e.f.
  • March 01, 2019. The diagnostic center under the name of 'M/s.
  • Gian Pathology and X-Rays' was first established in Kanpur in year 1995 by Mr. Arun Kumar Gupta (MD Pathology) which has been taken-over by the Company.
  • Mr. Arun Kumar Gupta completed his degree in Pathology from G.S.V.M. Medical College in Kanpur.

About Thyrocare Technologies Ltd

  • Thyrocare Technologies Limited was incorporated in January, 2000.
  • The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2024, the Company offered 929 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
  • Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
  • The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).

Gian Lifecare Ltd News Hub

News

Gian Lifecare to discuss results

Gian Lifecare will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

11 Feb 2025 12:50

News

Gian Lifecare to table results

Gian Lifecare will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

09 Nov 2024 11:58

News

Gian Lifecare to conduct AGM

Gian Lifecare announced that the 6th Annual General Meeting (AGM) of the company will be h...

Read more

13 Sep 2024 09:58

News

Gian Lifecare to hold board meeting

Gian Lifecare will hold a meeting of the Board of Directors of the Company on 23 August 20...

Read more

16 Aug 2024 10:25

News

Gian Lifecare Ltd leads losers in 'B' group

Shreeji Translogistics Ltd, Signet Industries Ltd, Murae Organisor Ltd and Avro India Ltd ...

Read more

16 Aug 2024 14:45

News

Gian Lifecare to conduct board meeting

Gian Lifecare will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

10 Aug 2024 11:17

Thyrocare Technologies Ltd News Hub

News

Thyrocare Tech spurts as Q1 PAT jumps 61% YoY to Rs 39 cr

Profit before tax stood at Rs 50.48 crore in Q1 FY26, registering a growth of 50.46% from ...

Read more

24 Jul 2025 12:14

News

Thyrocare Technologies schedules board meeting

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

17 Jul 2025 10:16

News

Thyrocare Technologies to hold AGM

Thyrocare Technologies announced that the 25th Annual General Meeting(AGM) of the company ...

Read more

07 Jul 2025 17:23

News

Thyrocare Technologies allots 996 equity shares under ESOS

Thyrocare Technologies has allotted 996 equity shares under ESOS. With this allotment, the...

Read more

21 May 2025 13:19

News

Thyrocare Tech spurts as Q4 PAT jumps 22% YoY to Rs 22 cr; declares dividend of Rs 21/sh

Profit before tax (PBT) for the March quarter stood at Rs 47.19 crore, marking a robust 10...

Read more

24 Apr 2025 10:07

News

Board of Thyrocare Technologies recommends Final Dividend

Thyrocare Technologies announced that the Board of Directors of the Company at its meeting...

Read more

23 Apr 2025 16:32

SWOT Analysis Of Gian Lifecare Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of Thyrocare Technologies Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Gian Lifecare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Thyrocare Technologies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gian Lifecare Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Gian Lifecare Ltd or Thyrocare Technologies Ltd?

Market cap of Gian Lifecare Ltd is 17 Cr while Market cap of Thyrocare Technologies Ltd is 6,950 Cr

What are the key factors driving the stock performance of Gian Lifecare Ltd and Thyrocare Technologies Ltd?

The stock performance of Gian Lifecare Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gian Lifecare Ltd and Thyrocare Technologies Ltd?

As of July 26, 2025, the Gian Lifecare Ltd stock price is INR ₹16.55. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹1311.6.

How do dividend payouts of Gian Lifecare Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Gian Lifecare Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions